ATTO · NASDAQ · Biotechnology

Atento S.A. (ATTO)

$20.74
At close−0.56 (−2.63%)

In millions of USD, except per-share figures

In millionsQ1 FY25Mar 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue000
Cost of revenue000
Gross profit000
162022
Research & development121719
Selling, general & administrative433
Operating income−16−20−22
111
Interest income111
Income before tax−15−19−21
Net income from continuing operations−15−19−21
Net income−15−19−21
EPS, basic−$0.40−$0.48−$0.45
EPS, diluted−$0.40−$0.48−$0.45
Weighted average shares, basic393946
Weighted average shares, diluted393946
EBITDA−16−20−22
Depreciation & amortization000
EBIT−16−20−22